ASA Connect

Early registration is now open for AIPM 2024, a uniquely invaluable and timely platform for statisticians, data scientists, regulators, and other professionals to address the challenges and opportunities of AI in pharmaceutical medicine and medical research; to foster collaboration among industry, academia, regulatory agencies, and professional associations; and to propose recommendations with policy implications for proper implementation of AI in promoting public health.

The annual symposium is jointly sponsored by Pfizer Inc., Northeastern University, and the American Statistical Association.

The theme of this year’s conference is “Generative AI in Medical Research and Drug Development – Hype or Reality?” 

Highlights of the conference include a panel discussion by experts in the field and a keynote address by Dr. Patrizia Cavazzoni, Director, Center for Drug Evaluation and Research, U.S. Food & Drug Administration. 

The symposium is scheduled for June 10-11, 2024, at the Northeastern University campus in Boston, MA.

Further details about the symposium, which may be attended in-person or virtually, can be found at: https://aipm.provost.northeastern.edu/.